Drug-Induced Intracranial Hypertension: The Adverse Effects of Acne Medications and Topical Retinoids
We propose treatment guidelines highlighting that patients taking a DIIH medication who develop headaches or visual changes should be immediately referred to ophthalmology, removal of the offending agent, and close monitoring by ophthalmology for vision loss. Importantly, vitamin A DIIH may have more severe visual outcomes, but further research is needed to corroborate this finding.
Authors
- Devon A. Cohen (ORCID: https://orcid.org/0000-0002-0160-8435)
- Jacqueline K. Shaia (ORCID: https://orcid.org/0000-0001-7873-669X)
- Katherine E. Talcott (ORCID: https://orcid.org/0000-0003-0458-4181)
- Rishi P. Singh
- Jenna R Rock
Institutions
- Cleveland Clinic Lerner College of Medicine (US)
- Cleveland Eye Clinic (US)
Publication Details
- Journal
- Journal of Neuro-Ophthalmology
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1097/wno.0000000000002236
- Citations
- 3
- Primary Topic
- Cerebral Venous Sinus Thrombosis
- Type
- article
- Field-Weighted Citation Impact
- 1.11
Funders
- Research to Prevent Blindness
- National Eye Institute